학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 8건 | 목록
1~20
Academic Journal
Cadernos de Tradução, Vol 42, Iss esp. 1 (2022)
Cadernos de Tradução; Vol. 42 No. esp. 1 (2022): Traduzindo a Amazônia II; 54-63
Cadernos de Tradução; Vol. 42 Núm. esp. 1 (2022): Traduzindo a Amazônia II; 54-63
Cadernos de Tradução; v. 42 n. esp. 1 (2022): Traduzindo a Amazônia II; 54-63
Cadernos de Tradução (Florianópolis. Online)
Universidade Federal de Santa Catarina (UFSC)
instacron:UFSC
Cadernos de Tradução; Vol. 42 No. esp. 1 (2022): Traduzindo a Amazônia II; 54-63
Cadernos de Tradução; Vol. 42 Núm. esp. 1 (2022): Traduzindo a Amazônia II; 54-63
Cadernos de Tradução; v. 42 n. esp. 1 (2022): Traduzindo a Amazônia II; 54-63
Cadernos de Tradução (Florianópolis. Online)
Universidade Federal de Santa Catarina (UFSC)
instacron:UFSC
Academic Journal
Cadernos de Tradução, Volume: 42, Issue: spe1, Pages: 54-63, Published: 01 SEP 2023
Academic Journal
Meulenhoff PC; Universitair Medisch Centrum Utrecht, Apotheek, divisie Laboratoria en Apotheek, Utrecht, The Neterlands. w.meulenhoff@umcutrecht.nl; van Reij EM; Egberts TC
Publisher: Vereniging NTvG Country of Publication: Netherlands NLM ID: 0400770 Publication Model: Print Cited Medium: Internet ISSN: 1876-8784 (Electronic) Linking ISSN: 00282162 NLM ISO Abbreviation: Ned Tijdschr Geneeskd Subsets: MEDLINE
Editorial & Opinion
Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Print ISSN: 1079-2082 (Print) Linking ISSN: 10792082 NLM ISO Abbreviation: Am J Health Syst Pharm Subsets: MEDLINE
Academic Journal
Bartelink IH; Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California.; van Reij EM; Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.; Gerhardt CE; Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, The Netherlands.; van Maarseveen EM; Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.; de Wildt A; Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, The Netherlands.; Versluys B; Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, The Netherlands.; Lindemans CA; Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, The Netherlands.; Bierings MB; Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, The Netherlands.; Boelens JJ; Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, The Netherlands; U-DANCE, Section Tumorimmunology, Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: j.j.boelens@umcutrecht.nl.
Publisher: Carden Jennings Publishing Country of Publication: United States NLM ID: 9600628 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-6536 (Electronic) Linking ISSN: 10838791 NLM ISO Abbreviation: Biol Blood Marrow Transplant Subsets: MEDLINE
Academic Journal
Bartelink IH; Department of Medicine, University of California San Francisco, CA, USA.; Lalmohamed A; Clinical Pharmacy Department, University Medical Center Utrecht, Utrecht, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands.; van Reij EM; Clinical Pharmacy Department, University Medical Center Utrecht, Utrecht, Netherlands.; Dvorak CC; Pediatric Allergy, Immunology, and Bone Marrow Transplantation Division, University of California San Francisco, CA, USA.; Savic RM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, CA, USA.; Zwaveling J; Leiden University Medical Center, Leiden, Netherlands.; Bredius RG; Leiden University Medical Center, Leiden, Netherlands.; Egberts AC; Clinical Pharmacy Department, University Medical Center Utrecht, Utrecht, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands.; Bierings M; Division of Pediatrics, Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, Netherlands.; Kletzel M; Stem Cell Transplant Program, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA.; Shaw PJ; Division of Blood and Marrow Transplantation, The Children's Hospital at Westmead, Sydney, NSW, Australia.; Nath CE; Division of Blood and Marrow Transplantation, The Children's Hospital at Westmead, Sydney, NSW, Australia.; Hempel G; Department of Clinical Pharmacy, Westfälische Wilhelms-Universität Münster, Institut für Pharmazeutische und Medizinische Chemie, Münster, Germany.; Ansari M; Département de l'Enfant et de l'Adolescent, Hôpital des Enfants, Geneva, Switzerland.; Krajinovic M; Charles-Bruneau Cancer Center, Department of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, QC, Canada.; Théorêt Y; Department of Pharmacology, University of Montreal, Montreal, QC, Canada; Clinical Pharmacology Unit, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC, Canada.; Duval M; Charles-Bruneau Cancer Center, Department of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, QC, Canada.; Keizer RJ; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, CA, USA; InsightRX, San Francisco, CA, USA.; Bittencourt H; Charles-Bruneau Cancer Center, Department of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, QC, Canada.; Hassan M; Division of Experimental Cancer Medicine, Clinical Research Centre, Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Güngör T; Division of Stem Cell Transplantation and Children's Research Center, University Children's Hospital Zürich, Zürich, Switzerland.; Wynn RF; Department of Haematology and Bone Marrow Transplantation, The Royal Manchester Children's Hospital, Manchester, UK.; Veys P; Bone Marrow Transplantation Department, Great Ormond Street Hospital for Children, London, UK.; Cuvelier GD; CancerCare Manitoba, Winnipeg, MB, Canada.; Marktel S; Stem Cell Program, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Chiesa R; Bone Marrow Transplantation Department, Great Ormond Street Hospital for Children, London, UK; Stem Cell Program, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Cowan MJ; Pediatric Allergy, Immunology, and Bone Marrow Transplantation Division, University of California San Francisco, CA, USA.; Slatter MA; The Institute of Cellular Medicine, Newcastle University, Newcastle, UK.; Stricherz MK; Department of Hematopoietic Cell Transplant, Hematology, and Oncology, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, USA.; Jennissen C; Department of Hematopoietic Cell Transplant, Hematology, and Oncology, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, USA.; Long-Boyle JR; Department of Clinical Pharmacy, University of California San Francisco, CA, USA.; Boelens JJ; Division of Pediatrics, Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, Netherlands; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands. Electronic address: j.j.boelens@umcutrecht.nl.
Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE
Brazilian Journal of Microbiology, Volume: 31, Issue: 1, Pages: 01-08, Published: MAR 2000. March 2000
Academic Journal
Epilepsia. Dec, 2006, Vol. 47 Issue s3, p169, 36 p.
검색 결과 제한하기
제한된 항목
[검색어] van Reij, EM
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어